Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term

Universal Health Services (UHS) is presented as a notable value stock, currently holding a Zacks Rank #3 (Hold) but distinguished by an 'A' rating for both its Value and overall VGM Style Scores. This assessment is underpinned by an attractive forward P/E ratio of 9.41 and recent positive analyst revisions, with five analysts increasing fiscal 2025 earnings estimates, pushing the Zacks Consensus Estimate up by $0.90 to $20.28 per share. The company's consistent average earnings surprise of +9.4% further bolsters its profile, suggesting potential for investors despite its current hold recommendation.

Analysis

Universal Health Services (UHS) presents a compelling value case despite its neutral Zacks #3 (Hold) rating, supported by 'A' grades for its Value and overall VGM Style Scores. The stock's valuation is highlighted by an attractive forward P/E ratio of 9.41. Analyst sentiment is showing positive momentum, with five analysts revising fiscal 2025 earnings estimates upward in the past 60 days. This has lifted the Zacks Consensus Estimate for that period by $0.90 to $20.28 per share. Furthermore, the company's history of outperformance is evidenced by an average positive earnings surprise of 9.4%. The combination of a low valuation, upward earnings revisions, and a track record of beating expectations suggests underlying strength, even though the current rank indicates a lack of immediate, powerful price catalysts.

Key Decisions for Investors

• Value-focused investors should consider UHS's attractive valuation, evidenced by a forward P/E of 9.41 and an 'A' Value Score, as a potential entry point for a long-term position.
• Investors should monitor for a potential upgrade of the Zacks Rank from #3 (Hold) to #2 (Buy), as the positive trend in fiscal 2025 earnings estimate revisions could serve as a leading indicator for a more bullish short-term outlook.
• While fundamentals appear strong, the 'Hold' rating warrants some caution for those seeking near-term gains, as it implies the absence of significant catalysts expected to drive the share price over the next 30 days.